P30AG072972

UC Davis Alzheimer's Disease Research Center - Project Summary/Abstract

Overall, the mission of the UC Davis Alzheimer's Disease Research Center (UCD ADRC) is to promote a highly innovative and enriched research environment focused on understanding the heterogeneity of brain aging among diverse populations that will ultimately lead to effective therapies to prevent or mitigate dementia. This approach stems from the premise that emphasizing diversity enhances discovery and contributes to translational science as well as reducing disparities in brain health and care.

To accomplish this mission, the UCD ADRC has developed innovative methods and a unique study design to recruit and retain a highly demographic diverse clinical and autopsy cohort. All UCD ADRC participants are longitudinally followed and deeply phenotyped with extensive clinical, blood, and imaging biomarker measures as well as developing state-of-the-art quantitative neuropathology.

The UCD ADRC succeeds at these efforts through a robust research infrastructure, state-of-the-art database management, and a highly collaborative environment consisting of seven well-integrated resource cores and one research education component (REC) designed to facilitate new research efforts and interventions, dissemination of research findings, education and training, as well as encouraging researcher development.

Our approach addresses several milestones set by the National Alzheimer's Project Act to effectively treat Alzheimer's disease and associated disorders (ADRD) by 2025. These include, but are not limited to:

1) M1.L., evaluating disparities among ethnic and racial minority populations that are at higher risk for AD to mitigate risk and improve cognitive outcomes,
2) M2.H., fully characterizing mixed pathologies and identifying unique risk factors,
3) M5-7., accelerating the development of treatments that would prevent, halt, or reverse the course of Alzheimer's disease (AD),
4) M9., improving early diagnosis through discovery of novel imaging and blood biomarkers,
5) M8., developing novel dementia prevention strategies, and
6) M13.E., supporting caregiving through funded caregiver research.

The UCD ADRC also directly supports multiple epidemiological studies of diverse communities through the use of research methods and personnel to gain further insights into dementia risk reduction, early diagnosis, and the impact of various neuropathologies on aging and dementia.

Our efforts reflect the evolving needs of an increasingly older and more diverse US population, which is expected to rise to nearly 14 million by midcentury. Moreover, while AD continues to be the major pathological cause of dementia, more recent studies - including one from the UCD ADRC - find that dementia pathology is multifactorial and highly heterogeneous, due in part to the co-occurrence of AD and vascular disease, which varies by ethnoracial characteristics, is emphasized as part of dementia prediction, and which can be modified by treatment even in later life.

The UCD ADRC is uniquely qualified to support this research focus with a considerable impact on future ADRD diagnosis and treatment.

Davis University Of California

NOT APPLICABLE

93.866 - Aging Research

National Institute on Aging (NIA) [HHS - NIH]

Sacramento, California 958167042 United States

Single Zip Code

Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed) (RFA-AG-21-019)

Amendment Since initial award the total obligations have increased 306% from $3,129,162 to $12,704,546.